health
FDA approves the first treatment for Alexander disease
The FDA has approved zilganersen for children and adults with Alexander disease, making it the first approved therapy for the rare neurological disorder.
Khabre desk
Rare disease
Recent reporting, analysis and explainers from the Rare disease desk.